The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Page 210
American Medical Association. 1984. Report of Ad Hoc Commission
on Vaccines Injury Compensation. Chicago.
American Medical Association, Ad Hoc Panel on Pertussis Vaccine
Injury. 1985. Pertussis vaccine injury. Journal of the American
Medical Association 254:30833085.
American Psychiatric Association. 1968. Diagnostic and
statistical manual of mental disorders, 2nd edition (DSM II).
Washington, DC: American Psychiatric Association.
American Psychiatric Association. 1980. Diagnostic and
statistical manual of mental disorders, 3rd edition (DSM III).
Washington, DC: American Psychiatric Association.
American Psychiatric Association. 1987. Diagnostic and
Statistical Manual of Mental Disorders, 3rd edition, revised (DSM
III-R). Washington, DC: American Psychiatric Association.
Amiel SA. 1976. The effects of Bordetella pertussis
vaccine on cerebral vascular permeability. British Journal of
Experimental Pathology 57:653-662.
Amiel-Tison C. 1973. Neurologic disorders in neonates associated
with abnormalities of pregnancy and birth. Current Problems of
Pediatrics 3:3-37.
Anderson EK. 1953. Serological studies on H. pertussis, H.
parapertussis, and H. bronchisepticus. Acta Pathologica
Microbiologica Scandinavica 33:202-224.
Anderson EL, Belshe RB, Bartram J. 1985. Clinical evaluation of
acellular pertussis DT vaccine in young children. Abstract E27.
Presented at the 85th Annual Meeting of the American Society for
Microbiology, Las Vegas.
Anderson EL, Belshe RB, Bartram J, Gurwith M, Hung P, Levner M,
Vernon SK. 1987. Clinical and serologic responses to acellular
pertussis vaccine in infants and young children. American Journal
of Diseases of Children 141:949-953.
Anderson EL, Belshe RB, Bartram J. 1988. Differences in
reactogenicity and antigenicity of acellular and standard pertussis
vaccines combined with diphtheria and tetanus in infants. Journal
of Infectious Diseases 157:731-737.
Anderson GR. 1976. Problems associated with the development and
clinical testing of an improved pertussis vaccine. In: Perlman D,
ed. Advances in Applied Microbiology, Vol. 20. Madison, WI:
Academic Press.
Anderson I, Morris D. 1950. Encephalopathy after combined
diphtheria-pertussis inoculation. Lancet 1:537-539.
Anderson R, May R. 1982. The logic of vaccination. New Scientist
96:410-415.
Angell M. 1990. The interpretation of epidemiologic studies. New
England Journal of Medicine 323:823-825.
Annegers JF, Hauser WA, Shirts SB, Kurland LT. 1987. Factors
prognostic of unprovoked seizures after febrile convulsions. New
England Journal of Medicine 316:493498.
Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT. 1988.
The risk of unprovoked seizures after encephalitis and meningitis.
Neurology 38:1407-1410.
Aoyama T, Murase Y, Kato T, Iwata T. 1985. Efficacy of an
acellular pertussis vaccine in Japan. Journal of Pediatrics
107:180-183.
Aoyama T, Hagiwara S, Murase Y, Kato T, Iwata T. 1986. Adverse
reactions and antibody responses to acellular pertussis vaccine.
Journal of Pediatrics 109:925930.